EcoDrugPlus

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSPLAG00000017556
Gene Symbol: LOC106956234
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSPLAG00000007907
Gene Symbol: LOC106949861
3 Cross references
203 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSPLAG00000006734
Gene Symbol: LOC106955062
3 Cross references
206 Possible Orthologues:

Integrin Alpha-8-Like

Ensembl ID : ENSPLAG00000003081
Gene Symbol: LOC106951149
3 Cross references
190 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSPLAG00000022732
Gene Symbol: LOC106964138
3 Cross references
228 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSPLAG00000022246
Gene Symbol: LOC106950752
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSPLAG00000018227
Gene Symbol: ITGA4
2 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPLAG00000000063
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSPLAG00000022567
Gene Symbol: ITGAV
3 Cross references
237 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPLAG00000010058
Gene Symbol: ITGB1
3 Cross references
214 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSPLAG00000011414
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSPLAG00000015452
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).